$18B+ in Cross-Border M&A: What the Merck KGaA and ON Semiconductor Deals Signal for Corporate Finance in 2025
Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B Synaptics deal signal a structural shift in cross-border M&A toward life sciences and AI hardware. European CFOs and M&A Directors must act now as regulatory complexity and mid-market re-rating accelerate.